Utility of Serum Free Light Chain Analysis When Screening for Lymphoproliferative Disorders

Utility of Serum Free Light Chain Analysis When Screening for Lymphoproliferative Disorders

Robson et al describe the experience of using serum FLC assays over a 2-month period to quantify FLCs in all serum samples requiring an SPE. The patient population included samples from individuals with a known monoclonal gammopathy and from those being screened for the presence of monoclonal immuno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Laboratory medicine 2009-06, Vol.40 (6), p.325
Hauptverfasser: Robson, Ewan JD, Taylor, Joanne, Beardsmore, Claire, Basu, Supratik, Mead, Graham, Lovatt, Tracy
Format: Artikel
Sprache:eng
Schlagworte:
Analysis
Cell growth
Medical disorders
Medical screening
Proteins
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Robson et al describe the experience of using serum FLC assays over a 2-month period to quantify FLCs in all serum samples requiring an SPE. The patient population included samples from individuals with a known monoclonal gammopathy and from those being screened for the presence of monoclonal immunoglobulin.
ISSN:0007-5027